Laminin 521

Laminin 521 Produktliste

Attribut
Protein (7)Kits (1)Panel (1)
Produktbibliothek
Online (9)
Spezies
Human (9)
Etikett
- (9)
Marker
Unconjugated (7)- (2)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Vorbestellen/Bestellen
HOT GMP-LA5H24	Human	HEK293	GMP Human Laminin 521 Protein	In den Warenkorb legen
HOT GMP-LA5H24GA02	Human	HEK293	GMP Human Laminin 521 Protein (Liquid)	In den Warenkorb legen
HOT LA5-H5213L	Human	HEK293	Human Laminin 521 Protein, premium grade (Liquid)	In den Warenkorb legen
HOT LA5-H5261	Human	HEK293	Human Laminin 521 Protein, premium grade	In den Warenkorb legen
LA5-H5217	Human	HEK293	Human Laminin 521 Protein, premium grade (Flagship Pro)	In den Warenkorb legen
LA5-H5246	Human	HEK293	Human Laminin 521 Protein, Research Grade (Flagship)	In den Warenkorb legen
LA5-H5248	Human	HEK293	Human Laminin 521 Protein, premium grade (Flagship)	In den Warenkorb legen
RES-A040	Human	-	resDetect™ Human Laminin 521 ELISA Kit (Residue Testing)	In den Warenkorb legen
SCC-01	Human	-	Laminin 521 Protein Screening Panel	In den Warenkorb legen

Gesamtmenge9

Laminin 521 Molekülhintergrund

Laminins are a major component of basement membranes. Each laminin molecule is a heterotrimeric glycoprotein composed of one α, one β, and one γ chain. To date, five α, three β, and three γ laminin chains have been identified that associate to form at least 15 laminin isoforms. Laminin 521 is found in the glomerular basement membrane in kidney, in the neuromuscular synaptic cleft in skeletal muscle and in other tissues such as placenta and lung.

Klinische Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Indikationen	Klinische Studie
HNC042	HNC-042	Phase 1 Clinical	Guangzhou Henovcom Bioscience Co Ltd	Influenza A virus infections; Influenza, Human; Influenza B virus infection	Details
Oseltamivir/Pimodivir		Phase 1 Clinical	Johnson & Johnson	Influenza A virus infections	Details
Oseltamivir orally disintegrating tablets	HY-100209	Phase 1 Clinical	Hefei Industrial Pharmaceutical Co Ltd	Influenza A virus infections; Influenza B virus infection	Details

Inverkehr gebrachte Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Frühestes Markenname	Frühestes Genehmigungsland	Früheste Indikation	Früheste Genehmigungsgesellschaft	Früheste Genehmigungsdatum	Indikationen	Klinische Studie
Laninamivir Octanoate Hydrate	CS-8958; R-118958	Approved	Daiichi Sankyo Co Ltd	Inavir	Japan	Influenza B virus infection; Influenza A virus infections; Influenza, Human	null	2010-09-10	Influenza A virus infections; Influenza, Human; Asthma; Influenza B virus infection	Details
Zanamivir	GG-167; GR-121167; GR-121167X; 4-Guanidino-Neu5Ac2en	Approved	Glaxosmithkline Plc	依乐韦, Relenza	United States	Influenza, Human	Glaxosmithkline Plc	1999-07-26	Orthomyxoviridae Infections; Diabetes Mellitus, Type 2; Influenza, Human; Arthralgia; Dengue	Details
Oseltamivir Phosphate	Ro-64-0796; GS-4104; RO-640796; GS-4104-002; EN-241104; RO-640796/002; GS-4104/002	Approved	F. Hoffmann-La Roche Ltd	Tamiflu, Hanmi Flu, 达菲	Switzerland	Influenza, Human	F. Hoffmann-La Roche Ltd	1999-09-21	Purpura, Thrombocytopenic, Idiopathic; Influenza A virus infections; Influenza, Human; Influenza in Birds; Obesity; Kidney Failure, Chronic	Details
Peramivir Hydrate	BCX-1812; JNJ-2; S-021812; RWJ-270201	Approved	Biocryst Pharmaceuticals Inc	Peramiflu, Alpivab, 力纬, Rapiacta, Rapivab, Enpiflu Premix	Japan	Influenza, Human	null	2010-01-13	Headache; Cough; Myalgia; Fatigue; Influenza A virus infections; Influenza, Human; Fever; Nasal Obstruction; Pharyngitis; Influenza B virus infection	Details